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Chromatin Modiﬁcations and Mast
Cell Migration in UV-Induced
Immunosuppression, an Epigenetic
Piece of The Puzzle
Remco van Doorn1 and Frank de Gruijl1
The migration of dermal mast cells to skin-draining lymph nodes is a key step in
UV-induced immunosuppression. Examining the effects of platelet-activating
factor (PAF), a phospholipid mediator secreted by keratinocytes following UV
exposure, on mast cells, Damiani et al. demonstrate that increased expression of
CXCR4 is associated with increased histone acetylation at the promoter of this
chemokine receptor gene.
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Exposure of the skin to ultraviolet (UV)
radiation causes local and systemic
suppression of T-cell mediated immune
responses in an antigen-speciﬁc fash-
ion. This immunosuppression has been
proposed to protect from the develop-
ment of auto-immunity directed against
neo-antigens induced by UV radiation
(Vermeer and Hurks, 1994). However,
impairment of T-cell effector function
caused by UV radiation also provides a
mechanism for the escape of incipient
neoplastic skin cells from anti-tumor
immune responses. The systemic immu-
nosuppressive effects of UV contribute
signiﬁcantly to the development of skin
cancer. At the same time beneﬁcial
effects of UV-induced immunosuppres-
sion are utilized in the clinical treatment
of atopic dermatitis, psoriasis and other
inﬂammatory skin diseases. Further
understanding of immunosuppressive
mechanisms activated by UV therefore
holds considerable relevance. The cas-
cade of events leading from UV expo-
sure of the skin to systemic suppression
of T-cell effector functions has intrigued
immunologists, and it has even led to
the development of a separate disci-
pline, photoimmunology.
In spite of four decades of photo-
immunological studies, it is still incom-
pletely understood how local skin
irradiation leads to systemic immune
effects. UV radiation has a relatively low
depth of skin penetration, yet it affects
T cells in distant lymph nodes. The
complex sequence of events proceeds
from molecules that absorb UV radia-
tion, DNA and membrane components
that become damaged and urocanic
acid that isomerizes from the trans to
the cis state. This in turn leads to
secretion of cytokines and other media-
tors that promote migration of Langer-
hans cells, dermal dendritic cells,
macrophages and mast cells from the
skin to skin-draining lymph nodes. Sub-
sequently these cells modulate T-cell
expansion and differentiation, with pre-
ferential generation of regulatory T-cell
subsets. The binding of cis-urocanic
acid to serotonin receptors cells has
been established as an important event
leading to suppression of immune
responses (Walterscheid et al., 2006).
PAF produced by keratinocytes
following UV exposure is another essen-
tial mediator of immunosuppressive
effects. PAF can bind to receptors on
dermal mast cells that are required for
the systemic suppression of immune
responses by UV radiation (Hart et al.,
1998). A considerable advance in the
ﬁeld of photoimmunology has been the
recognition that migration of dermal
mast cells towards skin-draining lymph
nodes is a key step in UV-induced
immunosuppression. Mast cell-deﬁcient
mutant cKitW-sh/W-sh mice are resistant
to UV-induced immunosuppression,
which can be restored by injecting bone
marrow-derived mast cells into the skin
of these mice (Chacón-Salinas et al.,
2014). By contrast, others have found
that UV-induced suppression of contact
hypersensitivity can be abolished
in basophil-deﬁcient mice, but this
did occur in mast cell-deﬁcient mice,
using different experimental condi-
tions (Meulenbroeks et al., 2015). In
the earlier study the research group
led by Stephen Ullrich demonstrated
that intraperitoneal injection of PAF in
mice activates the migration of mast
cells from the skin to draining lymph
nodes where they mediate immuno-
suppression (Chacón-Salinas et al.,
2014). Moreover, reconstituting mast
cell-deﬁcient mice with PAF receptor-
deﬁcient mast cells failed to restore
susceptibility to the immunosuppressive
effects of UV.
Motility of immune cells generally
involves the binding of chemokines that
form a gradient emanating from a
distant site to cognate receptors on the
cell surface. For dermal mast cells,
expression of the chemokine receptor
CXCR4 is essential for migration to
lymph nodes. UV irradiation of the skin
leads to expression of the chemokine
CXCL12 in lymph nodes, which can
bind to its receptor CXCR4 on mast cells
(Byrne et al., 2008). PAF acts by
simultaneously inducing expression of
CXCL12 by lymph node B cells and by
increasing the expression of CXCR4 on
mast cells (Byrne et al., 2008; Chacón-
Salinas et al., 2014). Novel insights into
the molecular mechanisms under-
lying the immunosuppressive effects of
UV radiation provide opportunities and
targets for preventing photocarcino-
genesis. Recent studies have shown
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that interfering with certain steps
in the cascade of events resulting in
immunosuppression after UV irradiation
of the skin reduces the development of
skin cancer in mice. Systemic
administration or local injection of a
PAF receptor antagonist (PCA-4248)
into the skin of UV-irradiated mice
signiﬁcantly suppressed induction of
squamous cell carcinomas (Sreevidya
et al., 2008). Treatment with AMD3100,
a small molecule antagonist of CXCR4,
inhibited UV radiation-induced devel-
opment of squamous cell carcinomas in
mice (Sarchio et al., 2014). Both
antagonists inhibit mast cell migration.
In addition, serotonin receptor
inhibitors by blocking cis-urocanic
acid binding and COX-2 inhibitors by
inhibiting prostaglandin E2 production
(also induced by PAF) diminish
UV-induced carcinogenesis (Sreevidya
et al., 2008).
In this issue of the Journal of Investi-
gative Dermatology Elisabetta Damiani
et al. illuminate another part of the UV-
induced immunosuppression puzzle
(Damiani et al., 2015). Using a human
transformed mast cell line (HMC-1) and
mast cells isolated from peripheral
blood, they demonstrate that exposure
of mast cells to PAF induces upregula-
tion of the chemokine receptor CXCR4,
which is associated with modulation of
certain epigenetic enzymes and histone
modiﬁcations at the CXCR4 gene
promoter. First, the authors conﬁrm
CXCR4 expression by the HMC-1 mast
cell line, and they then observe that
treatment with carbamyl-PAF (cPAF), a
metabolically stable PAF analog, causes
an increase in total and membrane-
bound CXCR4. Because promoter
methylation and histone modiﬁcations
have been implicated in the transcrip-
tional regulation of CXCR4 in several
cell types, the authors direct their
attention towards potential epigenetic
alterations induced by cPAF in
mast cells.
DNA is stored in a condensed form in
the nuclei of cells, wrapped around
histones and forming a DNA-protein
polymer known as chromatin. Chroma-
tin is a dynamic macromolecular
structure that can exist in different
conﬁgurations. The structure of chro-
matin can differ in packaging density,
which ranges from a relatively loose
form easily accessible to transcription
factors known as euchromatin, where
active gene transcription can take
place, to a highly condensed form
known as heterochromatin where tran-
scriptional activity is repressed. The
range of variation that exists in chromatin
structure can be modulated via several
mechanisms, including DNA methyla-
tion, histone modiﬁcations and chroma-
tin remodeling (Kouzarides, 2007).
Methylation of CpG islands in gene
promoters is often associated with
durable transcriptional downregulation.
A second mechanism by which changes
in chromatin structure are introduced is
the addition of post-translational modiﬁ-
cations to histone proteins within
nucleosomes. These post-translational
histone modiﬁcations include acetyla-
tion, methylation and phosphorylation at
different lysine and arginine residues,
each associated with activation or
repression of transcription of associated
genes. The presence of modiﬁcations
results in an altered electrostatic charge
and structure of a histone protein, and
these can attract chromatin remodeling
enzymes, impacting on chromatin acces-
sibility to transcription factors. A
dynamic interplay exists between tran-
scription factors and epigenetic enzymes
such as DNA methyltransferases and
histone modifying enzymes in the reg-
ulation of gene transcription. In general,
absence of promoter CpG island methy-
lation in conjunction with acetylation of
histone residues is correlated with open
chromatin. Histone methylation can be
correlated with transcriptional repression





new strategies to prevent
skin cancer.
Damiani et al. show in their study
that treatment of HMC-1 cells with
cPAF was associated with a signiﬁcant
decrease in the levels of the DNA
methyltransferase proteins DNMT1 and
DNMT3B. In addition, increased
expression of the histone acetyl trans-
ferase p300, coinciding with a decrease
of the histone deacetylase HDAC2,
was noted to follow cPAF treatment.
The observed changes in the levels
of these epigenetic enzymes, essential
for modulation and maintenance of
the epigenome following treatment
with cPAF, is remarkable. DNMT1 and
DNMT3B, as well as other chromatin
modifying enzymes, however, are
expressed in a cell cycle-dependent
fashion with low levels in the G1 phase
(Robertson et al., 2000). As PAF has
been shown previously to induce cell
cycle arrest in mast cells, the observed
effects of cPAF on DNA methyltrans-
ferase expression may be related in part
to their cell cycle-dependent expression
(Puebla-Osorio et al., 2015). In agree-
ment with the induction of epigenetic
modulation and histone acetylation by
cPAF, a signiﬁcant increase in total
acetylated histone H3 was found in
treated mast cells. In an attempt to
connect cPAF with epigenetic modula-
tion of CXCR4 expression, promoter
CpG island methylation of this gene
was examined. In untreated mast cells
such promoter CpG island methylation
was absent, which is perhaps not surpri-
sing given that CXCR4 was expressed
by HMC-1 cells, ﬁtting with an open
chromatin state at the CXCR4 locus.
However, an increase in acetylated
histone H3 (detected on lysine 9, 14,
18, 23, and 27) was detected in the
HMC-1 cell line and in freshly isolated
human mast cells after cPAF treatment
using chromatin immunoprecipitation
assays. As noted, histone H3 acetylation
is an activating histone mark that
generally deﬁnes chromatin regions
permissive for gene expression. The
relationship between upregulation of
membrane-bound CXCR4 on mast cells
and histone H3 acetylation at the
CXCR4 promoter was investigated
further by chemically inhibiting histone
acetylation. Treatment of cells exposed
to cPAF with curcumin, an inhibitor
of histone acetylation, strongly reduced
the expression of CXCR4 by mast cells.
This ﬁnding strengthens the possibility
that histone acetylation participates in
the regulation of CXCR4 expression
by cPAF.
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This study reveals a plausible connec-
tion between UV radiation, the lipid
mediator PAF and chromatin patterns in
immune cells of the skin. Although trans-
criptional regulation of gene expression
is commonly associated with histone
modiﬁcations, the profound effect of
PAF on several epigenetic regulators in
mast cells is noteworthy. It would be
interesting to investigate other genes that
may be regulated by PAF and to deter-
mine how epigenetic modulation,
including histone methylation, is
involved. Several other outstanding ques-
tions remain as well. They include the
signaling route from the G-protein
coupled receptor to which PAF binds
on mast cells to the induction of histone
modiﬁcations and binding of transcrip-
tion factors at the CXCR4 promoter
region. The cell-based assays performed
in this study also raise the question how
modulation of histone modifying
enzymes and epigenetic regulation of
CXCR4 in particular would impact on
mast cell migration, UV-induced immu-
nosuppression and skin carcinogenesis
in vivo. It is now increasingly recognized
that environmental stimuli can impact
on the epigenome of cells. The demon-
stration of PAF as a mediator of an
environmental factor that induces epige-
netic mechanisms of transcriptional reg-
ulation could be used as a model for
further study. Moreover, the identiﬁcation
of an epigenetic dimension operative in
photocarcinogenesis may provide further
opportunities for developing strategies to
prevent skin cancer.
CONFLICT OF INTEREST
The authors state no conﬂict of interest.
REFERENCES
Byrne SN, Limón-Flores AY, Ullrich SE (2008)
Mast cell migration from the skin to the
draining lymph nodes upon ultraviolet
irradiation represents a key step in the induc-
tion of immune suppression. J Immunol 180:
4648–55
Chacón-Salinas R, Chen L, Chávez-Blanco AD
et al. (2014) An essential role for platelet-
activating factor in activating mast cell migra-
tion following ultraviolet irradiation. J Leukoc
Biol 95:139–48
Damiani E, Puebla-Osorio N, Gorbea E et al. (2015)
Platelet-activating factor induces epigenetic
modiﬁcations in human mast cells. J Invest
Dermatol 135:3034–40
Hart PH, Grimbaldeston MA, Swift GJ et al. (1998)
Dermal mast cells determine susceptibility to
ultraviolet B-induced systemic suppression of
contact hypersensitivity responses in mice.
J Exp Med 187:2045–53
Kouzarides T (2007) Chromatin modiﬁcations and
their function. Cell 128:693–705
Meulenbroeks C, van Weelden H, Schwartz C
et al. (2015) Basophil-derived amphiregulin is
essential for UVB irradiation-induced immune
suppression. J Invest Dermatol 135:222–8
Puebla-Osorio N, Damiani E, Bover L et al. (2015)
Platelet-activating factor induces cell cycle
arrest and disrupts the DNA damage response
in mast cells. Cell Death Dis 6:e1745
Robertson KD, Keyomarsi K, Gonzales FA et al.
(2000) Differential mRNA expression of the
human DNA methyltransferases (DNMTs) 1,
3a and 3b during the G(0)/G(1) to S phase
transition in normal and tumor cells. Nucleic
Acids Res 28:2108–13
Sarchio SN, Scolyer RA, Beaugie C et al. (2014)
Pharmacologically antagonizing the CXCR4-
CXCL12 chemokine pathway with AMD3100
inhibits sunlight-induced skin cancer. J Invest
Dermatol 134:1091–100
Sreevidya CS, Khaskhely NM, Fukunaga A et al.
(2008) Inhibition of photocarcinogenesis by
platelet-activating factor or serotonin receptor
antagonists. Cancer Res 68:3978–84
Vermeer BJ, Hurks M (1994) The clinical relevance
of immunosuppression by UV irradiation
J Photochem Photobiol B 24:149–54
Walterscheid JP, Nghiem DX, Kazimi N et al.
(2006) Cis-urocanic acid, a sunlight-induced
immunosuppressive factor, activates immune
suppression via the 5-HT2A receptor. Proc
Natl Acad Sci USA 103:17420–5
See related article on pg 3078
Mutational Heterogeneity in
Melanoma: An Inconvenient Truth
Gregory A. Chang1,2 and David Polsky1,2
Identiﬁcation of oncogenic BRAF mutations in primary and metastatic melano-
mas supports a linear model of clonal evolution in cancer. Some mutational
studies, however, have failed to identify BRAF mutations in metastatic tumors
from patients with BRAFmutant primary melanomas. Using a combination of
methods, Riveiro-Falkenbach et al. (2015) assert that technical issues, and not
clonal heterogeneity, may explain prior discordant mutational results.
Journal of Investigative Dermatology (2015) 135, 2913–2918. doi:10.1038/jid.2015.351
Clonal evolution of cancers, proposed
in 1976 by Nowell (1976), states that
malignant tumors are genetically
unstable, producing clonal variants with
mutations that are either favorable or
unfavorable for cell survival. This linear
evolution model predicts that metastatic
and drug-resistant clones result from an
accumulation of several favorable muta-
tions, including the original initiating
mutation. With this conceptual frame-
work, a linear model of melanoma
tumorigenesis, beginning with the
development of a BRAFmutant nevus,
followed by additional genetic and
epigenetic alterations leads to primary
melanoma and ultimately to BRAFmutant
metastatic disease. This model makes
sense for BRAFmutant melanoma.
Evidence for BRAF mutational
heterogeneity in melanoma
Although the ﬁndings of many studies
are consistent with the model described
above, several have failed to identify
conservation of BRAF mutations in all
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